Showing results (201-210 of 2,229) with videos related to
Sort By:
Pageof 223
Cancer Biotherapy & Radiopharmaceuticals|February 24, 2001
Comparative dosimetry of copper-64 and yttrium-90-labeled somatostatin analogs in a tumor-bearing rat modelJ S Lewis, R Laforest, M R Lewis, et al.Cancer Biotherapy & Radiopharmaceuticals|February 24, 2001
Mitogen immunotherapy for HIV infections exemplified by phytohemagglutinin and pokeweed mitogenB M Wimer, P L MannCancer Biotherapy & Radiopharmaceuticals|October 25, 2002
Chemotherapy and bone marrow reserve: lessons learned from autologous stem cell transplantationIvan Aksentijevich, Ian FlinnCancer Biotherapy & Radiopharmaceuticals|June 2, 2001
Preclinical evaluation of a humanized NR-LU-10 antibody-streptavidin fusion protein for pretargeted cancer therapyS Goshorn, J Sanderson, D Axworthy, et al.Cancer Biotherapy & Radiopharmaceuticals|June 14, 2003
Effect of gelatins on human cancer cells in vitroTakashi Kojima, Tatsuro Koide, Hiroshi Nagata, et al.Cancer Biotherapy & Radiopharmaceuticals|June 14, 2003
An overview of attenuation and scatter correction of planar and SPECT data for dosimetry studiesMichael King, Troy FarncombeCancer Biotherapy & Radiopharmaceuticals|June 14, 2003
Impact of interpatient pharmacokinetic variability on design considerations for therapy with radiolabeled MAbsGerald DeNardo, Aina Yuan, Desiree Goldstein, et al.Cancer Biotherapy & Radiopharmaceuticals|September 5, 2003
Comparison of biodistribution, dosimetry, and outcome from clinical trials of radionuclide-CC49 antibody therapyRuby Meredith, Sui Shen, Daniel Macey, et al.Cancer Biotherapy & Radiopharmaceuticals|September 5, 2003
Image processing tools for alpha-particle track-etch dosimetryJohn C Roeske, Christina Soyland, Steven J Wang, et al.Cancer Biotherapy & Radiopharmaceuticals|September 5, 2003
Biokinetics of iodide in man: refinement of current ICRP dosimetry modelsL Johansson, S Leide-Svegborn, S Mattsson, et al.Pageof 223